Ph.D., Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS)
TBA
Rick Doblin, Ph.D., Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS), explores how potential FDA, EMA, and global regulatory approval of MDMA-assisted therapy for PTSD may contribute to a post-prohibition future.